Source: BioSpace

Acetylon Pharmaceuticals: Acetylon Announces Upcoming Scientific Presentations On The Use Of Selective HDAC Inhibitors In Treating Genetic Blood Disorders And Cancers

Life Sciences Jobs ...

Read full article »
Acetylon Pharmaceuticals's Competitors | Acetylon Pharmaceuticals's News | Acetylon Pharmaceuticals's Financials
Stay up-to-date with the latest news on Acetylon Pharmaceuticals
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Walter C. Ogier's photo - President & CEO of Acetylon Pharmaceuticals

President & CEO

Walter C. Ogier

CEO Approval Rating

70/100

Read more
Stay up-to-date with the latest news on Acetylon Pharmaceuticals